Research Summary
AI-generated summary of this SEC filing
Ultralife Corp Reports Q2 2026 Financial Results
What Happened
- Ultralife Corporation announced its financial results for the quarter ended June 30, 2026. The company issued a press release on August 7, 2026 and filed an 8-K (Item 2.02) to disclose those results. The press release is attached as Exhibit 99.1 to the filing.
Key Details
- Filing date: August 7, 2026 (Form 8-K, Item 2.02).
- Reporting period: Quarter ended June 30, 2026 (Q2 2026 quarterly results).
- Disclosure: Press release announcing results attached as Exhibit 99.1.
- Interactive data: Inline XBRL cover page included with the filing.
Why It Matters
- The 8-K announces Ultralife’s latest quarterly earnings and revenue information, which are primary drivers of short-term stock moves and investor assessments of operational performance.
- Retail investors should read the attached press release (and any related SEC filings) for the detailed numbers—revenue, net income or loss, segment results, and any forward-looking commentary or guidance—to evaluate the company’s recent performance and liquidity trends.
- This filing is a routine earnings disclosure; any material changes in results or outlook will be reflected in the press release and subsequent filings.